AU2002214942A1 - Analogues and derivatives of gastrin releasing peptide (grp) - Google Patents

Analogues and derivatives of gastrin releasing peptide (grp)

Info

Publication number
AU2002214942A1
AU2002214942A1 AU2002214942A AU1494202A AU2002214942A1 AU 2002214942 A1 AU2002214942 A1 AU 2002214942A1 AU 2002214942 A AU2002214942 A AU 2002214942A AU 1494202 A AU1494202 A AU 1494202A AU 2002214942 A1 AU2002214942 A1 AU 2002214942A1
Authority
AU
Australia
Prior art keywords
grp
analogues
derivatives
releasing peptide
gastrin releasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214942A
Other languages
English (en)
Inventor
Per Franklin Nielsen
Ulla Ribel-Madsen
Peter Andreas Nicolai Reumert Wagtmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2002214942A1 publication Critical patent/AU2002214942A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57572—Gastrin releasing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002214942A 2000-11-16 2001-11-12 Analogues and derivatives of gastrin releasing peptide (grp) Abandoned AU2002214942A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200001720 2000-11-16
DKPA200001720 2000-11-16
US25334500P 2000-11-28 2000-11-28
US60/253,345 2000-11-28
PCT/DK2001/000742 WO2002040537A2 (fr) 2000-11-16 2001-11-12 Analogues et derives du peptide liberateur de gastrine (gpr)

Publications (1)

Publication Number Publication Date
AU2002214942A1 true AU2002214942A1 (en) 2002-05-27

Family

ID=26068912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214942A Abandoned AU2002214942A1 (en) 2000-11-16 2001-11-12 Analogues and derivatives of gastrin releasing peptide (grp)

Country Status (3)

Country Link
US (1) US20020165148A1 (fr)
AU (1) AU2002214942A1 (fr)
WO (1) WO2002040537A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
EP2187935A2 (fr) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Utilisation du peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe seul ou en combinaison avec le peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh en tant qu'agent thérapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
AU4112497A (en) * 1996-08-30 1998-03-19 Novo Nordisk A/S Glp-2 derivatives
JP3842042B2 (ja) * 1998-01-29 2006-11-08 ポリ−メド・インコーポレーテッド 吸収可能なマイクロ粒子

Also Published As

Publication number Publication date
WO2002040537A3 (fr) 2002-09-26
WO2002040537A2 (fr) 2002-05-23
US20020165148A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
AU3381900A (en) Parallel testing of integrated circuit devices using cross-dut and within-dut comparisons
IL147802A0 (en) Sustained release formulation of a peptide
AU2000265051A1 (en) Vasoactive intestinal peptide analogs
AU4843500A (en) Destructible surfactants and uses thereof
AU2001235363A1 (en) Mibefradil analogues and their use
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2001228662A1 (en) Hyperpolarization of a gas
AU2001252559A1 (en) Preparations for evaluating eliminative ability of stomach
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU2002214942A1 (en) Analogues and derivatives of gastrin releasing peptide (grp)
AU2001261837A1 (en) Automatic configuration of equipment and software
AU4742101A (en) Antagonists of gonadotropin releasing hormone
AU4738101A (en) Antagonists of gonadotropin releasing hormone
IL153276A0 (en) Metalloprotease peptide substrates and methods
AU2002231267A1 (en) Analogues of thiocoraline and BE-22179
AU2001264900A1 (en) Pharmaceutical use of fibulin-1
AU6109698A (en) Analgesic peptides from venom of (grammostola spatulata) and use thereof
AU2001277750A1 (en) Use of polypeptide
AU1798100A (en) Use of peptide
AU2002222811A1 (en) Peptides from ag85 of mycobacterium and uses thereof
AU2001232051A1 (en) Relative orientation of bodies and associated apparatus
AU2001233333A1 (en) Par4 peptides and polypeptides
AU1415301A (en) Use of peptide
AU3245300A (en) N-trityl and n-phenylfluorenyl carboxyanhydrides of amino acids
GB0202889D0 (en) Peptides (assay)